AVE 20.0% 0.3¢ avecho biotechnology limited

re czd, page-36

  1. 5,322 Posts.
    Thanks for explanation JV. I retract my observation .
    These December figs for CZD and our projections for POHs earnings are a drop in the pond compared to what surely must unfold once BodyShaper hits US TV screens later this year. Underpin that with sales across Asia thru Watsons and 2012 should be a stellar year for personal care sales.

    I'll also predict that we see Muliple Ann's per month now going forward . I believe today signals the end of the newsflow drought. There is simply too much in the POH pipeline that is now due ( and well overdue ) for the company to remain quiet now that 2012 is underway . We have arrived at the business end of POHs commercial rollout . Let the deals and games commence.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.001(20.0%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $3.722K 1.413M

Buyers (Bids)

No. Vol. Price($)
53 94288418 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 76032683 22
View Market Depth
Last trade - 16.10pm 03/09/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.